

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transmembrane transport (GO:0006855) | 7.82764518 |
| 2 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.69558069 |
| 3 | urate metabolic process (GO:0046415) | 7.55294617 |
| 4 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 6.60161091 |
| 5 | drug transport (GO:0015893) | 6.55529096 |
| 6 | organic cation transport (GO:0015695) | 6.51711438 |
| 7 | lysine metabolic process (GO:0006553) | 6.39123367 |
| 8 | lysine catabolic process (GO:0006554) | 6.39123367 |
| 9 | positive regulation of glycolytic process (GO:0045821) | 6.02343926 |
| 10 | response to mercury ion (GO:0046689) | 5.98610028 |
| 11 | phosphate ion transport (GO:0006817) | 5.90091485 |
| 12 | endocrine pancreas development (GO:0031018) | 5.69072061 |
| 13 | excretion (GO:0007588) | 5.60215871 |
| 14 | peripheral nervous system neuron development (GO:0048935) | 5.49093176 |
| 15 | quaternary ammonium group transport (GO:0015697) | 5.36284752 |
| 16 | negative regulation of gluconeogenesis (GO:0045721) | 5.22378589 |
| 17 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 5.19542188 |
| 18 | negative regulation of protein oligomerization (GO:0032460) | 5.14256372 |
| 19 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.99244697 |
| 20 | glyoxylate metabolic process (GO:0046487) | 4.97292831 |
| 21 | fatty acid homeostasis (GO:0055089) | 4.91491560 |
| 22 | renal absorption (GO:0070293) | 4.90137557 |
| 23 | positive regulation of respiratory burst (GO:0060267) | 4.83663828 |
| 24 | regulation of glucokinase activity (GO:0033131) | 4.80997094 |
| 25 | regulation of hexokinase activity (GO:1903299) | 4.80997094 |
| 26 | phosphate ion transmembrane transport (GO:0035435) | 4.78230633 |
| 27 | exogenous drug catabolic process (GO:0042738) | 4.72921370 |
| 28 | tricarboxylic acid metabolic process (GO:0072350) | 4.71510415 |
| 29 | response to water (GO:0009415) | 4.68284185 |
| 30 | drug catabolic process (GO:0042737) | 4.65329629 |
| 31 | cysteine metabolic process (GO:0006534) | 4.64499446 |
| 32 | negative regulation of acute inflammatory response (GO:0002674) | 4.64371670 |
| 33 | glutathione biosynthetic process (GO:0006750) | 4.57866169 |
| 34 | insulin secretion (GO:0030073) | 4.53555316 |
| 35 | lactate metabolic process (GO:0006089) | 4.52213765 |
| 36 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.46331172 |
| 37 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 4.44197286 |
| 38 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 4.44197286 |
| 39 | metanephric tubule development (GO:0072170) | 4.41890264 |
| 40 | metanephric nephron tubule development (GO:0072234) | 4.41890264 |
| 41 | glycoside metabolic process (GO:0016137) | 4.40354079 |
| 42 | positive regulation of insulin secretion (GO:0032024) | 4.38663142 |
| 43 | positive regulation of peptide hormone secretion (GO:0090277) | 4.35488454 |
| 44 | aspartate family amino acid catabolic process (GO:0009068) | 4.35162918 |
| 45 | nitric oxide mediated signal transduction (GO:0007263) | 4.34298988 |
| 46 | epithelial cell fate commitment (GO:0072148) | 4.19794099 |
| 47 | positive regulation of peptide secretion (GO:0002793) | 4.18637230 |
| 48 | ketone body metabolic process (GO:1902224) | 4.17067036 |
| 49 | negative regulation of hormone biosynthetic process (GO:0032353) | 4.12458834 |
| 50 | polyol transport (GO:0015791) | 4.05177745 |
| 51 | amino-acid betaine transport (GO:0015838) | 4.04498227 |
| 52 | carnitine transport (GO:0015879) | 4.04498227 |
| 53 | metanephric nephron epithelium development (GO:0072243) | 4.02380427 |
| 54 | short-chain fatty acid metabolic process (GO:0046459) | 3.99750978 |
| 55 | positive regulation of protein autophosphorylation (GO:0031954) | 3.97827959 |
| 56 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.94404760 |
| 57 | L-phenylalanine metabolic process (GO:0006558) | 3.94404760 |
| 58 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.94377899 |
| 59 | branched-chain amino acid metabolic process (GO:0009081) | 3.90500596 |
| 60 | detection of calcium ion (GO:0005513) | 3.88612469 |
| 61 | vitamin D metabolic process (GO:0042359) | 3.88387659 |
| 62 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.84756476 |
| 63 | negative regulation of hormone metabolic process (GO:0032351) | 3.83780316 |
| 64 | positive regulation of glycogen biosynthetic process (GO:0045725) | 3.78558312 |
| 65 | detection of temperature stimulus (GO:0016048) | 3.73519626 |
| 66 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.72143564 |
| 67 | L-phenylalanine catabolic process (GO:0006559) | 3.72143564 |
| 68 | 2-oxoglutarate metabolic process (GO:0006103) | 3.68980431 |
| 69 | valine metabolic process (GO:0006573) | 3.68878459 |
| 70 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.68582183 |
| 71 | metanephric epithelium development (GO:0072207) | 3.67836111 |
| 72 | glandular epithelial cell differentiation (GO:0002067) | 3.67527532 |
| 73 | negative regulation of glycogen metabolic process (GO:0070874) | 3.67325741 |
| 74 | actin filament depolymerization (GO:0030042) | 3.66304560 |
| 75 | inositol phosphate catabolic process (GO:0071545) | 3.65642386 |
| 76 | type B pancreatic cell development (GO:0003323) | 3.62958243 |
| 77 | NADH metabolic process (GO:0006734) | 3.61339171 |
| 78 | cellular modified amino acid catabolic process (GO:0042219) | 3.58472441 |
| 79 | toxin transport (GO:1901998) | 3.58266375 |
| 80 | signal peptide processing (GO:0006465) | 3.57892435 |
| 81 | fructose metabolic process (GO:0006000) | 3.57711894 |
| 82 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.55424296 |
| 83 | peptide biosynthetic process (GO:0043043) | 3.47164577 |
| 84 | * sodium ion transport (GO:0006814) | 3.46017799 |
| 85 | aromatic amino acid family catabolic process (GO:0009074) | 3.45978111 |
| 86 | inositol phosphate dephosphorylation (GO:0046855) | 3.45436327 |
| 87 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.45436327 |
| 88 | phosphate ion homeostasis (GO:0055062) | 3.45380172 |
| 89 | trivalent inorganic anion homeostasis (GO:0072506) | 3.45380172 |
| 90 | glycerophospholipid catabolic process (GO:0046475) | 3.44265718 |
| 91 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.40956511 |
| 92 | regulation of insulin secretion (GO:0050796) | 3.40823412 |
| 93 | auditory receptor cell differentiation (GO:0042491) | 3.37903688 |
| 94 | chemosensory behavior (GO:0007635) | 3.36716597 |
| 95 | positive regulation of glycogen metabolic process (GO:0070875) | 3.34274888 |
| 96 | regulation of glycolytic process (GO:0006110) | 3.31051283 |
| 97 | respiratory chain complex IV assembly (GO:0008535) | 3.30475214 |
| 98 | neuronal action potential (GO:0019228) | 3.29296314 |
| 99 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.29112167 |
| 100 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.29045549 |
| 101 | adenosine metabolic process (GO:0046085) | 3.28157136 |
| 102 | nephron tubule development (GO:0072080) | 3.27160518 |
| 103 | xenobiotic catabolic process (GO:0042178) | 3.26265207 |
| 104 | modified amino acid transport (GO:0072337) | 3.25098794 |
| 105 | positive regulation of hormone secretion (GO:0046887) | 3.24404225 |
| 106 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.24110680 |
| 107 | acetyl-CoA metabolic process (GO:0006084) | 3.21427769 |
| 108 | membrane repolarization (GO:0086009) | 3.19997576 |
| 109 | regulation of energy homeostasis (GO:2000505) | 3.19239990 |
| 110 | homocysteine metabolic process (GO:0050667) | 3.18993851 |
| 111 | fatty acid beta-oxidation (GO:0006635) | 3.18898985 |
| 112 | sodium ion export (GO:0071436) | 3.17156581 |
| 113 | tryptophan catabolic process (GO:0006569) | 3.16881819 |
| 114 | indole-containing compound catabolic process (GO:0042436) | 3.16881819 |
| 115 | indolalkylamine catabolic process (GO:0046218) | 3.16881819 |
| 116 | serine family amino acid catabolic process (GO:0009071) | 3.16454452 |
| 117 | regulation of peptide hormone secretion (GO:0090276) | 3.16094834 |
| 118 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.15783779 |
| 119 | potassium ion export (GO:0071435) | 3.15678477 |
| 120 | branched-chain amino acid catabolic process (GO:0009083) | 3.13832913 |
| 121 | glutathione metabolic process (GO:0006749) | 3.11218690 |
| 122 | positive regulation of vasodilation (GO:0045909) | 3.09916076 |
| 123 | amino-acid betaine metabolic process (GO:0006577) | 3.09787646 |
| 124 | regulation of peptide secretion (GO:0002791) | 3.08681417 |
| 125 | peptide hormone secretion (GO:0030072) | 3.07923929 |
| 126 | cellular ketone body metabolic process (GO:0046950) | 3.07692013 |
| 127 | peptide hormone processing (GO:0016486) | 3.05293689 |
| 128 | cellular potassium ion homeostasis (GO:0030007) | 3.04330813 |
| 129 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.04278620 |
| 130 | dendritic spine morphogenesis (GO:0060997) | 3.03315015 |
| 131 | phenylpropanoid metabolic process (GO:0009698) | 3.02050029 |
| 132 | proline metabolic process (GO:0006560) | 3.01436328 |
| 133 | nucleoside diphosphate catabolic process (GO:0009134) | 3.01253789 |
| 134 | negative regulation of neurological system process (GO:0031645) | 2.99947018 |
| 135 | positive regulation of TOR signaling (GO:0032008) | 2.99496564 |
| 136 | peptide secretion (GO:0002790) | 2.97310498 |
| 137 | tricarboxylic acid cycle (GO:0006099) | 2.97279797 |
| 138 | response to parathyroid hormone (GO:0071107) | 2.96817167 |
| 139 | response to glucose (GO:0009749) | 2.96338169 |
| 140 | cytochrome complex assembly (GO:0017004) | 2.95969563 |
| 141 | oxaloacetate metabolic process (GO:0006107) | 2.95734008 |
| 142 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.95341589 |
| 143 | tryptophan metabolic process (GO:0006568) | 2.94438085 |
| 144 | polyol catabolic process (GO:0046174) | 2.94149368 |
| 145 | beta-amyloid metabolic process (GO:0050435) | 2.93584297 |
| 146 | cell volume homeostasis (GO:0006884) | 2.93418771 |
| 147 | carnitine metabolic process (GO:0009437) | 2.92297589 |
| 148 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.91797638 |
| 149 | lipid oxidation (GO:0034440) | 2.91080884 |
| 150 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.90250074 |
| 151 | cellular response to zinc ion (GO:0071294) | 2.90108182 |
| 152 | serine family amino acid metabolic process (GO:0009069) | 2.89644042 |
| 153 | fatty acid oxidation (GO:0019395) | 2.89442421 |
| 154 | macroautophagy (GO:0016236) | 2.88142344 |
| 155 | response to growth hormone (GO:0060416) | 2.87391430 |
| 156 | renal tubule development (GO:0061326) | 2.86795049 |
| 157 | regulation of protein glycosylation (GO:0060049) | 2.86543647 |
| 158 | mesenchymal cell differentiation involved in renal system development (GO:2001012) | 2.83971959 |
| 159 | mesenchymal cell differentiation involved in kidney development (GO:0072161) | 2.83971959 |
| 160 | righting reflex (GO:0060013) | 2.83504625 |
| 161 | regulation of acrosome reaction (GO:0060046) | 2.83486912 |
| 162 | brain morphogenesis (GO:0048854) | 2.83093369 |
| 163 | cytidine deamination (GO:0009972) | 2.80716704 |
| 164 | cytidine metabolic process (GO:0046087) | 2.80716704 |
| 165 | cytidine catabolic process (GO:0006216) | 2.80716704 |
| 166 | response to hexose (GO:0009746) | 2.80477259 |
| 167 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.80007068 |
| 168 | aromatic amino acid family metabolic process (GO:0009072) | 2.79052459 |
| 169 | * sodium ion transmembrane transport (GO:0035725) | 2.79037256 |
| 170 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.76980139 |
| 171 | regulation of hormone secretion (GO:0046883) | 2.76713346 |
| 172 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.75992063 |
| 173 | astrocyte differentiation (GO:0048708) | 2.75645210 |
| 174 | kidney morphogenesis (GO:0060993) | 2.75487698 |
| 175 | response to phenylpropanoid (GO:0080184) | 2.75250300 |
| 176 | fatty acid catabolic process (GO:0009062) | 2.74718957 |
| 177 | positive regulation of macroautophagy (GO:0016239) | 2.69428518 |
| 178 | glandular epithelial cell development (GO:0002068) | 2.67229462 |
| 179 | dentate gyrus development (GO:0021542) | 2.66002617 |
| 180 | positive regulation of meiosis (GO:0045836) | 2.64965181 |
| 181 | response to monosaccharide (GO:0034284) | 2.64444228 |
| 182 | regulation of carbohydrate catabolic process (GO:0043470) | 2.62785500 |
| 183 | regulation of cellular carbohydrate catabolic process (GO:0043471) | 2.62785500 |
| 184 | regulation of oxidative phosphorylation (GO:0002082) | 2.60895773 |
| 185 | calcium ion import (GO:0070509) | 2.60503036 |
| 186 | positive regulation of cellular carbohydrate metabolic process (GO:0010676) | 2.60064499 |
| 187 | regulation of autophagic vacuole assembly (GO:2000785) | 2.59158178 |
| 188 | positive regulation of glucose metabolic process (GO:0010907) | 2.57727348 |
| 189 | cell differentiation involved in metanephros development (GO:0072202) | 2.56126006 |
| 190 | regulation of protein autophosphorylation (GO:0031952) | 2.55273488 |
| 191 | peptide transport (GO:0015833) | 2.52501229 |
| 192 | platelet dense granule organization (GO:0060155) | 2.51858097 |
| 193 | hormone secretion (GO:0046879) | 2.50363287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.10400171 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.05603298 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.94775725 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 2.85361575 |
| 5 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.82794050 |
| 6 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.73655233 |
| 7 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.66765073 |
| 8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.60974202 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.50826244 |
| 10 | EGR1_19032775_ChIP-ChIP_M12_Human | 2.42762613 |
| 11 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.27140130 |
| 12 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.24119224 |
| 13 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.13943674 |
| 14 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.11361112 |
| 15 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.99495837 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.89149960 |
| 17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.80808960 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.78943712 |
| 19 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.74086631 |
| 20 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.72844428 |
| 21 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.72082458 |
| 22 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.71881055 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.70866560 |
| 24 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.66870488 |
| 25 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.61912147 |
| 26 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.60339268 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.58979447 |
| 28 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.55055855 |
| 29 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.54395935 |
| 30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.54395935 |
| 31 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.54058917 |
| 32 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.53121759 |
| 33 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.52398037 |
| 34 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.51653443 |
| 35 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.51073385 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.49424820 |
| 37 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.48923547 |
| 38 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48637345 |
| 39 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.47864614 |
| 40 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.47723752 |
| 41 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.46255930 |
| 42 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.46228762 |
| 43 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.45992739 |
| 44 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.43206301 |
| 45 | FUS_26573619_Chip-Seq_HEK293_Human | 1.42302406 |
| 46 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.41173810 |
| 47 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.40979078 |
| 48 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.40526899 |
| 49 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.40269905 |
| 50 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.39543034 |
| 51 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.39208667 |
| 52 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.39032388 |
| 53 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.39004087 |
| 54 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.38582841 |
| 55 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.38433937 |
| 56 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.36662265 |
| 57 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.36038463 |
| 58 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.35322555 |
| 59 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.32990357 |
| 60 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.31699032 |
| 61 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.29201765 |
| 62 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.29068913 |
| 63 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.28649942 |
| 64 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.28519721 |
| 65 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.27972140 |
| 66 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.27887013 |
| 67 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.26694813 |
| 68 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.26555099 |
| 69 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.26551921 |
| 70 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.25296989 |
| 71 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.23896958 |
| 72 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.23353474 |
| 73 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.23110872 |
| 74 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.22943665 |
| 75 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.22673624 |
| 76 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.22673624 |
| 77 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22289528 |
| 78 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.22215376 |
| 79 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.21918147 |
| 80 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.20868134 |
| 81 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.19944259 |
| 82 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.18059204 |
| 83 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.17850063 |
| 84 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.17555522 |
| 85 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17253338 |
| 86 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.15874691 |
| 87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15710170 |
| 88 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.15537085 |
| 89 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.13540064 |
| 90 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.13540064 |
| 91 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.13530821 |
| 92 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.13525591 |
| 93 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12592327 |
| 94 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.11731553 |
| 95 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.11731553 |
| 96 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.10785637 |
| 97 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.10234847 |
| 98 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.09656074 |
| 99 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.08758609 |
| 100 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.08080310 |
| 101 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.08018078 |
| 102 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.07821915 |
| 103 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.07516435 |
| 104 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.06113805 |
| 105 | TBL1_22424771_ChIP-Seq_293T_Human | 1.05982421 |
| 106 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.05742652 |
| 107 | * AR_20517297_ChIP-Seq_VCAP_Human | 1.05634670 |
| 108 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.05404911 |
| 109 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.05195418 |
| 110 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.05110805 |
| 111 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.05045380 |
| 112 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.04703879 |
| 113 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.04626374 |
| 114 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04464225 |
| 115 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.04243847 |
| 116 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.03577515 |
| 117 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.03379823 |
| 118 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.03106933 |
| 119 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.02875086 |
| 120 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.01446587 |
| 121 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.01364884 |
| 122 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.01207609 |
| 123 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.00915578 |
| 124 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.00912483 |
| 125 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.00123473 |
| 126 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.99253076 |
| 127 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.99109080 |
| 128 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.98772122 |
| 129 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.98498118 |
| 130 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98375357 |
| 131 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.98191463 |
| 132 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97986849 |
| 133 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.97895243 |
| 134 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.97855720 |
| 135 | NFYA_21822215_ChIP-Seq_K562_Human | 0.97283894 |
| 136 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.97141117 |
| 137 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.97097288 |
| 138 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.97071790 |
| 139 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.96913034 |
| 140 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.96856394 |
| 141 | NFYB_21822215_ChIP-Seq_K562_Human | 0.96835203 |
| 142 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96253619 |
| 143 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.96071939 |
| 144 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95601837 |
| 145 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.95546797 |
| 146 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95385373 |
| 147 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.94917150 |
| 148 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93139412 |
| 149 | CJUN_26792858_Chip-Seq_BT549_Human | 0.92898431 |
| 150 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.91286045 |
| 151 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90558465 |
| 152 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89851605 |
| 153 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88464394 |
| 154 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87248551 |
| 155 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.86797817 |
| 156 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86509779 |
| 157 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.84894587 |
| 158 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.84570054 |
| 159 | KDM2B_26808549_Chip-Seq_K562_Human | 0.84248086 |
| 160 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.84216932 |
| 161 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84203322 |
| 162 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83547998 |
| 163 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.83354384 |
| 164 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.83306680 |
| 165 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.81596929 |
| 166 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.79872711 |
| 167 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.79473674 |
| 168 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.78862785 |
| 169 | P300_19829295_ChIP-Seq_ESCs_Human | 0.78846913 |
| 170 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.78839205 |
| 171 | SA1_27219007_Chip-Seq_Bcells_Human | 0.78474832 |
| 172 | PPARD_21283829_ChIP-Seq_MYOFIBROBLAST_Human | 0.78196831 |
| 173 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.77888627 |
| 174 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.76356218 |
| 175 | * TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.75690432 |
| 176 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.75284633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004043_abnormal_pH_regulation | 5.51275244 |
| 2 | MP0005360_urolithiasis | 5.12416132 |
| 3 | MP0002735_abnormal_chemical_nociception | 4.92380494 |
| 4 | MP0001968_abnormal_touch/_nociception | 4.53867449 |
| 5 | MP0002736_abnormal_nociception_after | 4.34558479 |
| 6 | MP0003195_calcinosis | 3.78659860 |
| 7 | MP0009780_abnormal_chondrocyte_physiolo | 3.76639758 |
| 8 | MP0005332_abnormal_amino_acid | 3.75917984 |
| 9 | MP0002909_abnormal_adrenal_gland | 3.75731925 |
| 10 | MP0003787_abnormal_imprinting | 3.73406920 |
| 11 | MP0002163_abnormal_gland_morphology | 3.61890007 |
| 12 | MP0005379_endocrine/exocrine_gland_phen | 3.53815238 |
| 13 | MP0001986_abnormal_taste_sensitivity | 3.42030036 |
| 14 | MP0001756_abnormal_urination | 3.33177005 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 3.23197910 |
| 16 | MP0009643_abnormal_urine_homeostasis | 3.19881027 |
| 17 | MP0001765_abnormal_ion_homeostasis | 3.19754653 |
| 18 | MP0002139_abnormal_hepatobiliary_system | 3.05923103 |
| 19 | MP0001944_abnormal_pancreas_morphology | 2.84280954 |
| 20 | MP0004858_abnormal_nervous_system | 2.67477901 |
| 21 | MP0005636_abnormal_mineral_homeostasis | 2.66322587 |
| 22 | MP0002733_abnormal_thermal_nociception | 2.64577369 |
| 23 | MP0005220_abnormal_exocrine_pancreas | 2.60856885 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 2.56540382 |
| 25 | MP0002693_abnormal_pancreas_physiology | 2.55191701 |
| 26 | MP0004270_analgesia | 2.50545012 |
| 27 | MP0002734_abnormal_mechanical_nocicepti | 2.43504476 |
| 28 | MP0002136_abnormal_kidney_physiology | 2.41328051 |
| 29 | MP0003122_maternal_imprinting | 2.28498067 |
| 30 | MP0003123_paternal_imprinting | 2.21825922 |
| 31 | MP0000013_abnormal_adipose_tissue | 2.11250496 |
| 32 | MP0001970_abnormal_pain_threshold | 2.09539575 |
| 33 | MP0006072_abnormal_retinal_apoptosis | 2.02802339 |
| 34 | MP0008877_abnormal_DNA_methylation | 2.00439891 |
| 35 | MP0000538_abnormal_urinary_bladder | 1.89415066 |
| 36 | MP0005377_hearing/vestibular/ear_phenot | 1.85038040 |
| 37 | MP0003878_abnormal_ear_physiology | 1.85038040 |
| 38 | MP0002078_abnormal_glucose_homeostasis | 1.80863448 |
| 39 | MP0008961_abnormal_basal_metabolism | 1.80569548 |
| 40 | MP0006276_abnormal_autonomic_nervous | 1.78521932 |
| 41 | MP0008875_abnormal_xenobiotic_pharmacok | 1.77084909 |
| 42 | MP0001958_emphysema | 1.72320263 |
| 43 | MP0003806_abnormal_nucleotide_metabolis | 1.68273512 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.67365168 |
| 45 | MP0005645_abnormal_hypothalamus_physiol | 1.64286995 |
| 46 | MP0010329_abnormal_lipoprotein_level | 1.59189969 |
| 47 | MP0005646_abnormal_pituitary_gland | 1.59012716 |
| 48 | MP0001270_distended_abdomen | 1.57652534 |
| 49 | MP0000462_abnormal_digestive_system | 1.50505307 |
| 50 | MP0004885_abnormal_endolymph | 1.42665238 |
| 51 | MP0003121_genomic_imprinting | 1.35959663 |
| 52 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.35704961 |
| 53 | MP0005085_abnormal_gallbladder_physiolo | 1.35258982 |
| 54 | MP0002638_abnormal_pupillary_reflex | 1.34359164 |
| 55 | MP0002090_abnormal_vision | 1.33928296 |
| 56 | MP0010678_abnormal_skin_adnexa | 1.31674123 |
| 57 | MP0002876_abnormal_thyroid_physiology | 1.30564113 |
| 58 | MP0000230_abnormal_systemic_arterial | 1.29917149 |
| 59 | MP0002067_abnormal_sensory_capabilities | 1.28274918 |
| 60 | MP0003186_abnormal_redox_activity | 1.25983615 |
| 61 | MP0003011_delayed_dark_adaptation | 1.23558921 |
| 62 | MP0008260_abnormal_autophagy | 1.23092867 |
| 63 | MP0001501_abnormal_sleep_pattern | 1.22160192 |
| 64 | MP0003953_abnormal_hormone_level | 1.19946458 |
| 65 | MP0003329_amyloid_beta_deposits | 1.18819042 |
| 66 | MP0006036_abnormal_mitochondrial_physio | 1.18589865 |
| 67 | MP0005083_abnormal_biliary_tract | 1.18421167 |
| 68 | MP0003252_abnormal_bile_duct | 1.16954992 |
| 69 | MP0005365_abnormal_bile_salt | 1.14847633 |
| 70 | MP0005551_abnormal_eye_electrophysiolog | 1.13024624 |
| 71 | MP0005535_abnormal_body_temperature | 1.10765955 |
| 72 | MP0002928_abnormal_bile_duct | 1.05879634 |
| 73 | MP0005448_abnormal_energy_balance | 1.05243761 |
| 74 | MP0000747_muscle_weakness | 1.02761710 |
| 75 | MP0000427_abnormal_hair_cycle | 0.98922462 |
| 76 | MP0000003_abnormal_adipose_tissue | 0.98658376 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 0.96910380 |
| 78 | MP0005253_abnormal_eye_physiology | 0.95084631 |
| 79 | MP0002168_other_aberrant_phenotype | 0.94443929 |
| 80 | MP0002277_abnormal_respiratory_mucosa | 0.94277839 |
| 81 | MP0005319_abnormal_enzyme/_coenzyme | 0.93216592 |
| 82 | MP0010234_abnormal_vibrissa_follicle | 0.91867694 |
| 83 | MP0005084_abnormal_gallbladder_morpholo | 0.90973140 |
| 84 | MP0009745_abnormal_behavioral_response | 0.89627803 |
| 85 | MP0005367_renal/urinary_system_phenotyp | 0.89586820 |
| 86 | MP0000516_abnormal_urinary_system | 0.89586820 |
| 87 | MP0002135_abnormal_kidney_morphology | 0.88991587 |
| 88 | MP0003300_gastrointestinal_ulcer | 0.88004248 |
| 89 | MP0002272_abnormal_nervous_system | 0.87985018 |
| 90 | MP0002557_abnormal_social/conspecific_i | 0.86988866 |
| 91 | MP0000639_abnormal_adrenal_gland | 0.82504418 |
| 92 | MP0000534_abnormal_ureter_morphology | 0.82473427 |
| 93 | MP0002751_abnormal_autonomic_nervous | 0.79617610 |
| 94 | MP0001905_abnormal_dopamine_level | 0.79534989 |
| 95 | MP0002938_white_spotting | 0.77621365 |
| 96 | MP0005386_behavior/neurological_phenoty | 0.76593568 |
| 97 | MP0004924_abnormal_behavior | 0.76593568 |
| 98 | MP0010386_abnormal_urinary_bladder | 0.75765368 |
| 99 | MP0000631_abnormal_neuroendocrine_gland | 0.75268323 |
| 100 | MP0003172_abnormal_lysosome_physiology | 0.74924741 |
| 101 | MP0002896_abnormal_bone_mineralization | 0.74010786 |
| 102 | MP0004142_abnormal_muscle_tone | 0.73000498 |
| 103 | MP0002102_abnormal_ear_morphology | 0.72457970 |
| 104 | MP0003646_muscle_fatigue | 0.71776630 |
| 105 | MP0005165_increased_susceptibility_to | 0.71719521 |
| 106 | MP0005075_abnormal_melanosome_morpholog | 0.71710198 |
| 107 | MP0002184_abnormal_innervation | 0.69486233 |
| 108 | MP0001764_abnormal_homeostasis | 0.69361673 |
| 109 | MP0002572_abnormal_emotion/affect_behav | 0.69205112 |
| 110 | MP0004859_abnormal_synaptic_plasticity | 0.68651488 |
| 111 | MP0003283_abnormal_digestive_organ | 0.68624018 |
| 112 | MP0000604_amyloidosis | 0.68443863 |
| 113 | MP0005389_reproductive_system_phenotype | 0.68423804 |
| 114 | MP0005174_abnormal_tail_pigmentation | 0.68174763 |
| 115 | MP0004742_abnormal_vestibular_system | 0.67907461 |
| 116 | MP0002160_abnormal_reproductive_system | 0.67679574 |
| 117 | MP0004085_abnormal_heartbeat | 0.67666055 |
| 118 | MP0003879_abnormal_hair_cell | 0.66196911 |
| 119 | MP0008874_decreased_physiological_sensi | 0.64802306 |
| 120 | MP0005452_abnormal_adipose_tissue | 0.63431571 |
| 121 | MP0000749_muscle_degeneration | 0.62752121 |
| 122 | MP0000383_abnormal_hair_follicle | 0.62312268 |
| 123 | MP0001664_abnormal_digestion | 0.62092149 |
| 124 | MP0000372_irregular_coat_pigmentation | 0.62034174 |
| 125 | MP0002254_reproductive_system_inflammat | 0.61939838 |
| 126 | MP0001661_extended_life_span | 0.61598636 |
| 127 | MP0002971_abnormal_brown_adipose | 0.61089109 |
| 128 | MP0002064_seizures | 0.61071904 |
| 129 | MP0000751_myopathy | 0.59961335 |
| 130 | MP0001666_abnormal_nutrient_absorption | 0.59328915 |
| 131 | MP0002118_abnormal_lipid_homeostasis | 0.59196383 |
| 132 | MP0009642_abnormal_blood_homeostasis | 0.58988214 |
| 133 | MP0002069_abnormal_eating/drinking_beha | 0.58672771 |
| 134 | MP0005451_abnormal_body_composition | 0.58226961 |
| 135 | MP0004147_increased_porphyrin_level | 0.56556156 |
| 136 | MP0002837_dystrophic_cardiac_calcinosis | 0.54627280 |
| 137 | MP0002089_abnormal_postnatal_growth/wei | 0.53282762 |
| 138 | MP0003638_abnormal_response/metabolism_ | 0.52318187 |
| 139 | MP0003633_abnormal_nervous_system | 0.51630115 |
| 140 | MP0004484_altered_response_of | 0.51213676 |
| 141 | MP0008872_abnormal_physiological_respon | 0.50317699 |
| 142 | MP0003191_abnormal_cellular_cholesterol | 0.50064036 |
| 143 | MP0003959_abnormal_lean_body | 0.50023860 |
| 144 | MP0003183_abnormal_peptide_metabolism | 0.49896951 |
| 145 | MP0010771_integument_phenotype | 0.48822884 |
| 146 | MP0008775_abnormal_heart_ventricle | 0.48240440 |
| 147 | MP0002972_abnormal_cardiac_muscle | 0.48129036 |
| 148 | MP0003635_abnormal_synaptic_transmissio | 0.46995100 |
| 149 | MP0002229_neurodegeneration | 0.46385098 |
| 150 | MP0001984_abnormal_olfaction | 0.45918724 |
| 151 | MP0003634_abnormal_glial_cell | 0.44554217 |
| 152 | MP0001440_abnormal_grooming_behavior | 0.44463400 |
| 153 | MP0005666_abnormal_adipose_tissue | 0.44397600 |
| 154 | MP0002066_abnormal_motor_capabilities/c | 0.44330137 |
| 155 | MP0009046_muscle_twitch | 0.42861383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic seizures (HP:0002173) | 7.98444387 |
| 2 | Metabolic alkalosis (HP:0200114) | 7.77603354 |
| 3 | Hypokalemic alkalosis (HP:0001949) | 7.63021447 |
| 4 | Hyperinsulinemic hypoglycemia (HP:0000825) | 7.53981929 |
| 5 | Increased circulating renin level (HP:0000848) | 7.44463024 |
| 6 | Hypoglycemic coma (HP:0001325) | 7.23018582 |
| 7 | Hyperactive renin-angiotensin system (HP:0000841) | 6.68131504 |
| 8 | Polyuria (HP:0000103) | 6.64072821 |
| 9 | Abnormality of chloride homeostasis (HP:0011422) | 6.61526256 |
| 10 | * Hypomagnesemia (HP:0002917) | 6.26617393 |
| 11 | Abnormal urine output (HP:0012590) | 6.16432372 |
| 12 | Gout (HP:0001997) | 5.95056009 |
| 13 | Abnormality of endocrine pancreas physiology (HP:0012093) | 5.79315323 |
| 14 | Abnormality of the pancreatic islet cells (HP:0006476) | 5.79315323 |
| 15 | Abnormality of renal excretion (HP:0011036) | 5.71608035 |
| 16 | * Abnormality of magnesium homeostasis (HP:0004921) | 5.52679660 |
| 17 | Hyperglycemia (HP:0003074) | 5.43482444 |
| 18 | Symptomatic seizures (HP:0011145) | 5.39061349 |
| 19 | Abnormal drinking behavior (HP:0030082) | 5.23006446 |
| 20 | Polydipsia (HP:0001959) | 5.23006446 |
| 21 | Renal salt wasting (HP:0000127) | 5.12089072 |
| 22 | Hyperaldosteronism (HP:0000859) | 5.01134298 |
| 23 | Alkalosis (HP:0001948) | 4.99076636 |
| 24 | Tetany (HP:0001281) | 4.79329537 |
| 25 | Abnormality of renin-angiotensin system (HP:0000847) | 4.52298323 |
| 26 | Large for gestational age (HP:0001520) | 4.48980960 |
| 27 | Late onset (HP:0003584) | 4.29678721 |
| 28 | Increased purine levels (HP:0004368) | 4.26882547 |
| 29 | Hyperuricemia (HP:0002149) | 4.26882547 |
| 30 | Proximal tubulopathy (HP:0000114) | 4.10962570 |
| 31 | Prominent metopic ridge (HP:0005487) | 4.03251119 |
| 32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.89717215 |
| 33 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.87757041 |
| 34 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.81551659 |
| 35 | Hypokalemia (HP:0002900) | 3.81103949 |
| 36 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.66272436 |
| 37 | Abnormality of the metopic suture (HP:0005556) | 3.61217501 |
| 38 | Abnormality of purine metabolism (HP:0004352) | 3.59538445 |
| 39 | Hypothermia (HP:0002045) | 3.58206822 |
| 40 | Hypercalciuria (HP:0002150) | 3.57552404 |
| 41 | Hyperglycinuria (HP:0003108) | 3.53268741 |
| 42 | Enlarged penis (HP:0000040) | 3.24212811 |
| 43 | Generalized aminoaciduria (HP:0002909) | 3.22870470 |
| 44 | EEG with generalized epileptiform discharges (HP:0011198) | 3.17881670 |
| 45 | Abnormality of potassium homeostasis (HP:0011042) | 3.15511516 |
| 46 | Epileptiform EEG discharges (HP:0011182) | 3.10113531 |
| 47 | Hypsarrhythmia (HP:0002521) | 3.03527022 |
| 48 | Renal tubular acidosis (HP:0001947) | 2.91639896 |
| 49 | Adrenal overactivity (HP:0002717) | 2.89114231 |
| 50 | Abnormal pancreas size (HP:0012094) | 2.87307128 |
| 51 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.81508572 |
| 52 | Abnormality of glycine metabolism (HP:0010895) | 2.80407192 |
| 53 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.80407192 |
| 54 | Hydroxyprolinuria (HP:0003080) | 2.79729986 |
| 55 | Abnormality of proline metabolism (HP:0010907) | 2.79729986 |
| 56 | Glycosuria (HP:0003076) | 2.78644153 |
| 57 | Abnormality of urine glucose concentration (HP:0011016) | 2.78644153 |
| 58 | Ketoacidosis (HP:0001993) | 2.77922005 |
| 59 | Type I diabetes mellitus (HP:0100651) | 2.71116324 |
| 60 | Abnormality of nucleobase metabolism (HP:0010932) | 2.67141868 |
| 61 | Abnormality of sodium homeostasis (HP:0010931) | 2.66367155 |
| 62 | Nephrocalcinosis (HP:0000121) | 2.65145530 |
| 63 | Hyperphosphaturia (HP:0003109) | 2.61021025 |
| 64 | Metaphyseal dysplasia (HP:0100255) | 2.58504434 |
| 65 | Pheochromocytoma (HP:0002666) | 2.52724505 |
| 66 | Hyperphosphatemia (HP:0002905) | 2.50590083 |
| 67 | Neoplasm of the adrenal cortex (HP:0100641) | 2.50169510 |
| 68 | Tongue fasciculations (HP:0001308) | 2.49543570 |
| 69 | Muscular hypotonia of the trunk (HP:0008936) | 2.49414647 |
| 70 | Neonatal onset (HP:0003623) | 2.46908069 |
| 71 | Delayed epiphyseal ossification (HP:0002663) | 2.46555144 |
| 72 | Hypokinesia (HP:0002375) | 2.43878184 |
| 73 | Hyponatremia (HP:0002902) | 2.43638312 |
| 74 | Facial shape deformation (HP:0011334) | 2.41985122 |
| 75 | Potter facies (HP:0002009) | 2.41985122 |
| 76 | Abnormality of vitamin B metabolism (HP:0004340) | 2.41904626 |
| 77 | Hemiparesis (HP:0001269) | 2.41019246 |
| 78 | Ketosis (HP:0001946) | 2.40281212 |
| 79 | Insulin resistance (HP:0000855) | 2.36960292 |
| 80 | Abnormal urine phosphate concentration (HP:0012599) | 2.36385472 |
| 81 | Hepatic necrosis (HP:0002605) | 2.35281536 |
| 82 | Unilateral renal agenesis (HP:0000122) | 2.32774644 |
| 83 | Methylmalonic acidemia (HP:0002912) | 2.30507517 |
| 84 | Neuroendocrine neoplasm (HP:0100634) | 2.28450149 |
| 85 | Nuclear cataract (HP:0100018) | 2.26484892 |
| 86 | Nephrolithiasis (HP:0000787) | 2.22695559 |
| 87 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.17666696 |
| 88 | Dehydration (HP:0001944) | 2.16229609 |
| 89 | Hematochezia (HP:0002573) | 2.14869925 |
| 90 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.13974325 |
| 91 | Bicornuate uterus (HP:0000813) | 2.12223317 |
| 92 | Hepatoblastoma (HP:0002884) | 2.11584594 |
| 93 | Conjunctival hamartoma (HP:0100780) | 2.11302809 |
| 94 | Hyperthyroidism (HP:0000836) | 2.11200463 |
| 95 | Abnormal sex determination (HP:0012244) | 2.10893127 |
| 96 | Sex reversal (HP:0012245) | 2.10893127 |
| 97 | Vomiting (HP:0002013) | 2.10369077 |
| 98 | Agitation (HP:0000713) | 2.10358545 |
| 99 | Muscle fibrillation (HP:0010546) | 2.10352741 |
| 100 | Abnormality of the renal cortex (HP:0011035) | 2.08891942 |
| 101 | Testicular neoplasm (HP:0010788) | 2.08716306 |
| 102 | Hypophosphatemia (HP:0002148) | 2.08158842 |
| 103 | Progressive macrocephaly (HP:0004481) | 2.06084490 |
| 104 | Malnutrition (HP:0004395) | 2.04585765 |
| 105 | Exocrine pancreatic insufficiency (HP:0001738) | 2.03644905 |
| 106 | Abnormality of the vocal cords (HP:0008777) | 2.00311450 |
| 107 | Hamartoma of the eye (HP:0010568) | 1.99812832 |
| 108 | Vacuolated lymphocytes (HP:0001922) | 1.95390834 |
| 109 | Abnormality of the costochondral junction (HP:0000919) | 1.94811521 |
| 110 | Axonal loss (HP:0003447) | 1.93955951 |
| 111 | Vascular calcification (HP:0004934) | 1.92782571 |
| 112 | Metaphyseal cupping (HP:0003021) | 1.89013313 |
| 113 | Abnormality of vitamin metabolism (HP:0100508) | 1.88956119 |
| 114 | Hyperglycinemia (HP:0002154) | 1.88776114 |
| 115 | Hyperammonemia (HP:0001987) | 1.88278606 |
| 116 | Renal tubular dysfunction (HP:0000124) | 1.87157026 |
| 117 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.86572808 |
| 118 | Albinism (HP:0001022) | 1.85095215 |
| 119 | Ventricular fibrillation (HP:0001663) | 1.85065678 |
| 120 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.84862821 |
| 121 | Myokymia (HP:0002411) | 1.84097924 |
| 122 | Ulnar claw (HP:0001178) | 1.83819797 |
| 123 | Hypotension (HP:0002615) | 1.83092453 |
| 124 | Chondrocalcinosis (HP:0000934) | 1.82902689 |
| 125 | Rickets (HP:0002748) | 1.81954593 |
| 126 | Xanthomatosis (HP:0000991) | 1.81445824 |
| 127 | Progressive neurologic deterioration (HP:0002344) | 1.81387970 |
| 128 | Dicarboxylic aciduria (HP:0003215) | 1.81385797 |
| 129 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.81385797 |
| 130 | Medial flaring of the eyebrow (HP:0010747) | 1.80859436 |
| 131 | Glomerulosclerosis (HP:0000096) | 1.80637769 |
| 132 | Abnormal tarsal ossification (HP:0008369) | 1.79086669 |
| 133 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.78402110 |
| 134 | Downturned corners of mouth (HP:0002714) | 1.78293120 |
| 135 | Tubular atrophy (HP:0000092) | 1.77539177 |
| 136 | Gaze-evoked nystagmus (HP:0000640) | 1.77403693 |
| 137 | Abnormality of renal resorption (HP:0011038) | 1.75638790 |
| 138 | Congenital malformation of the right heart (HP:0011723) | 1.75576646 |
| 139 | Double outlet right ventricle (HP:0001719) | 1.75576646 |
| 140 | Metabolic acidosis (HP:0001942) | 1.75454733 |
| 141 | Retinal atrophy (HP:0001105) | 1.74535430 |
| 142 | Insidious onset (HP:0003587) | 1.73671570 |
| 143 | Termporal pattern (HP:0011008) | 1.73671570 |
| 144 | Renal cortical cysts (HP:0000803) | 1.72018912 |
| 145 | Nausea (HP:0002018) | 1.71690607 |
| 146 | Neoplasm of the adrenal gland (HP:0100631) | 1.71416299 |
| 147 | Delayed CNS myelination (HP:0002188) | 1.70911063 |
| 148 | Macroorchidism (HP:0000053) | 1.70550573 |
| 149 | Increased CSF protein (HP:0002922) | 1.69986284 |
| 150 | Disproportionate short-trunk short stature (HP:0003521) | 1.68955493 |
| 151 | Lethargy (HP:0001254) | 1.68894646 |
| 152 | Impaired pain sensation (HP:0007328) | 1.68783144 |
| 153 | Abnormality of pain sensation (HP:0010832) | 1.68783144 |
| 154 | Abnormality of Sharpey fibers (HP:0100685) | 1.68490559 |
| 155 | Diminished movement (HP:0002374) | 1.68154808 |
| 156 | Cardiovascular calcification (HP:0011915) | 1.68062957 |
| 157 | Irritability (HP:0000737) | 1.67842214 |
| 158 | Tubulointerstitial fibrosis (HP:0005576) | 1.66779727 |
| 159 | Intestinal atresia (HP:0011100) | 1.66538626 |
| 160 | Generalized muscle weakness (HP:0003324) | 1.66400483 |
| 161 | Methylmalonic aciduria (HP:0012120) | 1.64626028 |
| 162 | Decreased circulating renin level (HP:0003351) | 1.64251419 |
| 163 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.64245241 |
| 164 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.64245241 |
| 165 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.64245241 |
| 166 | Enlarged kidneys (HP:0000105) | 1.61979511 |
| 167 | Abnormal eating behavior (HP:0100738) | 1.61907019 |
| 168 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.61416499 |
| 169 | Mucopolysacchariduria (HP:0008155) | 1.61416499 |
| 170 | Pancreatic cysts (HP:0001737) | 1.60291178 |
| 171 | Sensorimotor neuropathy (HP:0007141) | 1.58798722 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 7.34602864 |
| 2 | WNK3 | 7.23965350 |
| 3 | OXSR1 | 6.03205022 |
| 4 | FGFR2 | 4.27122160 |
| 5 | STK39 | 3.62870587 |
| 6 | PASK | 3.13221353 |
| 7 | SGK494 | 2.36603850 |
| 8 | SGK223 | 2.36603850 |
| 9 | NTRK1 | 2.20994601 |
| 10 | KSR2 | 2.02385695 |
| 11 | MAP3K2 | 1.88408363 |
| 12 | MAP4K2 | 1.84252686 |
| 13 | NEK1 | 1.83660158 |
| 14 | SGK2 | 1.82738691 |
| 15 | GRK5 | 1.81096064 |
| 16 | BCKDK | 1.79998468 |
| 17 | GRK1 | 1.77377803 |
| 18 | STK38L | 1.74958782 |
| 19 | RIPK4 | 1.71621311 |
| 20 | WNK1 | 1.66148753 |
| 21 | INSRR | 1.55040689 |
| 22 | NLK | 1.54327351 |
| 23 | PDK4 | 1.49163133 |
| 24 | PDK3 | 1.49163133 |
| 25 | LIMK1 | 1.43800925 |
| 26 | BMPR1B | 1.43400265 |
| 27 | MINK1 | 1.42953501 |
| 28 | SGK3 | 1.41694329 |
| 29 | HIPK2 | 1.40778447 |
| 30 | MAP3K9 | 1.35350952 |
| 31 | EIF2AK3 | 1.34647131 |
| 32 | SIK3 | 1.33960271 |
| 33 | PNCK | 1.32229710 |
| 34 | ACVR1B | 1.32172125 |
| 35 | TRPM7 | 1.27390981 |
| 36 | PINK1 | 1.22324367 |
| 37 | ARAF | 1.21666465 |
| 38 | TNIK | 1.12434497 |
| 39 | MST4 | 1.11604565 |
| 40 | LMTK2 | 1.05215316 |
| 41 | TAOK1 | 1.03701338 |
| 42 | RET | 1.01329509 |
| 43 | PTK2B | 0.99334143 |
| 44 | PRKAA2 | 0.98136718 |
| 45 | STK3 | 0.97241157 |
| 46 | AKT3 | 0.97108660 |
| 47 | MATK | 0.96951850 |
| 48 | MARK3 | 0.95652651 |
| 49 | MAP3K12 | 0.94460642 |
| 50 | FER | 0.92369369 |
| 51 | PDK2 | 0.92344726 |
| 52 | EPHB1 | 0.91299418 |
| 53 | STK16 | 0.89935849 |
| 54 | DAPK2 | 0.89667370 |
| 55 | CAMK2D | 0.88842675 |
| 56 | FGFR4 | 0.88182067 |
| 57 | EPHA3 | 0.87321297 |
| 58 | MST1R | 0.85587432 |
| 59 | STK24 | 0.80506235 |
| 60 | CSNK1G1 | 0.79433224 |
| 61 | STK11 | 0.75427245 |
| 62 | MAP2K1 | 0.75148107 |
| 63 | CASK | 0.74818996 |
| 64 | STK38 | 0.74029331 |
| 65 | TESK1 | 0.68479389 |
| 66 | ERBB3 | 0.68032047 |
| 67 | BLK | 0.67848189 |
| 68 | LRRK2 | 0.67628360 |
| 69 | MAPKAPK3 | 0.65944014 |
| 70 | MAP3K1 | 0.63988774 |
| 71 | FRK | 0.62878240 |
| 72 | TNK2 | 0.62625645 |
| 73 | PAK6 | 0.61134312 |
| 74 | PKN2 | 0.60679611 |
| 75 | ZAK | 0.59723378 |
| 76 | PTK2 | 0.58522359 |
| 77 | MAP2K2 | 0.58271068 |
| 78 | RPS6KA2 | 0.50729655 |
| 79 | MAP2K4 | 0.49484709 |
| 80 | CSNK1G3 | 0.48722955 |
| 81 | PRKG1 | 0.48321285 |
| 82 | CAMK1G | 0.46905190 |
| 83 | PRKD3 | 0.46257236 |
| 84 | PRKG2 | 0.45878175 |
| 85 | PLK2 | 0.45259952 |
| 86 | MAP3K11 | 0.44021261 |
| 87 | PDPK1 | 0.43192335 |
| 88 | IKBKB | 0.43044723 |
| 89 | PLK3 | 0.42463828 |
| 90 | STK4 | 0.42279149 |
| 91 | SGK1 | 0.42059101 |
| 92 | CSNK1G2 | 0.40283160 |
| 93 | ROCK1 | 0.39579205 |
| 94 | LATS2 | 0.38880461 |
| 95 | NTRK3 | 0.38643820 |
| 96 | FLT3 | 0.38587243 |
| 97 | PHKG1 | 0.38233683 |
| 98 | PHKG2 | 0.38233683 |
| 99 | CAMKK2 | 0.38198436 |
| 100 | TAOK3 | 0.37907662 |
| 101 | PRKCZ | 0.37688383 |
| 102 | CDK14 | 0.37632768 |
| 103 | PAK3 | 0.37497104 |
| 104 | TAF1 | 0.35799143 |
| 105 | TESK2 | 0.35189049 |
| 106 | PDK1 | 0.33971197 |
| 107 | MET | 0.32684082 |
| 108 | PRKAA1 | 0.32295534 |
| 109 | CDK5 | 0.32208002 |
| 110 | MAP2K7 | 0.31800422 |
| 111 | MAPKAPK5 | 0.31775352 |
| 112 | PRKCD | 0.31757015 |
| 113 | GSK3A | 0.31272314 |
| 114 | EIF2AK1 | 0.30674595 |
| 115 | CSNK1A1 | 0.29086678 |
| 116 | KSR1 | 0.28382779 |
| 117 | YES1 | 0.28360398 |
| 118 | BCR | 0.28107217 |
| 119 | FGFR3 | 0.27995696 |
| 120 | PIM2 | 0.27450204 |
| 121 | ADRBK1 | 0.27322412 |
| 122 | CAMK2A | 0.26632500 |
| 123 | IRAK1 | 0.25837611 |
| 124 | SCYL2 | 0.25347166 |
| 125 | BRSK2 | 0.25248843 |
| 126 | CDK3 | 0.25184115 |
| 127 | PRKACG | 0.24801181 |
| 128 | PRKACB | 0.24789866 |
| 129 | PRKACA | 0.24588030 |
| 130 | PRKCE | 0.24366969 |
| 131 | ITK | 0.23858087 |
| 132 | ADRBK2 | 0.23855522 |
| 133 | MYLK | 0.22954019 |
| 134 | ABL2 | 0.22415806 |
| 135 | NEK9 | 0.22307704 |
| 136 | MAP2K6 | 0.21998550 |
| 137 | PRKCG | 0.21935984 |
| 138 | PRKCH | 0.20750571 |
| 139 | PRKCQ | 0.20687826 |
| 140 | IRAK4 | 0.19633055 |
| 141 | DAPK1 | 0.19618027 |
| 142 | IRAK2 | 0.19565526 |
| 143 | MAPK11 | 0.19132675 |
| 144 | PRKCI | 0.19095641 |
| 145 | MAP3K7 | 0.18170739 |
| 146 | MAP3K4 | 0.17973376 |
| 147 | GRK6 | 0.16180520 |
| 148 | NME2 | 0.15543553 |
| 149 | PRKCA | 0.15521270 |
| 150 | EPHB2 | 0.15446927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 8.23079359 |
| 2 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.56320483 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.32512304 |
| 4 | * Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.23518061 |
| 5 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.16292020 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.99287716 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.73085888 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.72765337 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.71006555 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.61544116 |
| 11 | Protein export_Homo sapiens_hsa03060 | 2.59907782 |
| 12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.53969455 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.48174084 |
| 14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.37594266 |
| 15 | * Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.33009784 |
| 16 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.23733774 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.19033898 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.15375705 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 2.14670203 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.87492690 |
| 21 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.85750845 |
| 22 | * Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.80028210 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.79722730 |
| 24 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.76987930 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.76928487 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.76270574 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.74717117 |
| 28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.63281406 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.62326494 |
| 30 | Carbon metabolism_Homo sapiens_hsa01200 | 1.57025915 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.44107811 |
| 32 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.39520162 |
| 33 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.38268181 |
| 34 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.37925642 |
| 35 | Circadian rhythm_Homo sapiens_hsa04710 | 1.30867615 |
| 36 | * Bile secretion_Homo sapiens_hsa04976 | 1.28381823 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.28380135 |
| 38 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.28180433 |
| 39 | Parkinsons disease_Homo sapiens_hsa05012 | 1.23919524 |
| 40 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.22999263 |
| 41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.22938446 |
| 42 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.20775370 |
| 43 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.19437997 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.18496716 |
| 45 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.18422109 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.17873249 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.16990810 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.16750974 |
| 49 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.14802531 |
| 50 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.11657614 |
| 51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01219223 |
| 52 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.00617519 |
| 53 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 0.98983121 |
| 54 | Renin secretion_Homo sapiens_hsa04924 | 0.94034165 |
| 55 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.91854789 |
| 56 | * Mineral absorption_Homo sapiens_hsa04978 | 0.88950393 |
| 57 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.88399996 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.87136009 |
| 59 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.83749611 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.83582578 |
| 61 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.82239431 |
| 62 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.82026209 |
| 63 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.80611749 |
| 64 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.80027920 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.75608280 |
| 66 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.73158473 |
| 67 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.71893336 |
| 68 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.70739508 |
| 69 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.70150097 |
| 70 | Alzheimers disease_Homo sapiens_hsa05010 | 0.70024562 |
| 71 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.69502954 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.69140665 |
| 73 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.68262718 |
| 74 | Phototransduction_Homo sapiens_hsa04744 | 0.67706374 |
| 75 | Taste transduction_Homo sapiens_hsa04742 | 0.67544954 |
| 76 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67251768 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.64269015 |
| 78 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.64114087 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63828382 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.62981431 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.62066373 |
| 82 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61835231 |
| 83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.59604079 |
| 84 | * Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58647871 |
| 85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.56968901 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.56529913 |
| 87 | Histidine metabolism_Homo sapiens_hsa00340 | 0.54215840 |
| 88 | GABAergic synapse_Homo sapiens_hsa04727 | 0.54116457 |
| 89 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.52846550 |
| 90 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.52592476 |
| 91 | Lysine degradation_Homo sapiens_hsa00310 | 0.52367855 |
| 92 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.52156997 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.50363971 |
| 94 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.50133359 |
| 95 | Huntingtons disease_Homo sapiens_hsa05016 | 0.49520297 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.49392801 |
| 97 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.49225348 |
| 98 | Circadian entrainment_Homo sapiens_hsa04713 | 0.48971659 |
| 99 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48769148 |
| 100 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47676404 |
| 101 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47207155 |
| 102 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46884792 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45561903 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.45365510 |
| 105 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.45360057 |
| 106 | Thyroid cancer_Homo sapiens_hsa05216 | 0.43822415 |
| 107 | Phagosome_Homo sapiens_hsa04145 | 0.42391480 |
| 108 | * Pancreatic secretion_Homo sapiens_hsa04972 | 0.41091639 |
| 109 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.39445855 |
| 110 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.39180911 |
| 111 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38861864 |
| 112 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.38366230 |
| 113 | Cocaine addiction_Homo sapiens_hsa05030 | 0.37180117 |
| 114 | Long-term depression_Homo sapiens_hsa04730 | 0.35946680 |
| 115 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.35772368 |
| 116 | Basal transcription factors_Homo sapiens_hsa03022 | 0.34202022 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31401626 |
| 118 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.28739244 |
| 119 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.27940970 |
| 120 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.27315226 |
| 121 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.27236261 |
| 122 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.27013509 |
| 123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.26824060 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.25762783 |
| 125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.25373719 |
| 126 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.23681888 |
| 127 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.22371006 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.22315505 |
| 129 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.21697106 |
| 130 | Endometrial cancer_Homo sapiens_hsa05213 | 0.19791547 |
| 131 | Bladder cancer_Homo sapiens_hsa05219 | 0.19146962 |
| 132 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.18924493 |
| 133 | Melanoma_Homo sapiens_hsa05218 | 0.18039756 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.17260076 |
| 135 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.16307282 |
| 136 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.15471128 |
| 137 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.14424160 |
| 138 | Glioma_Homo sapiens_hsa05214 | 0.10558235 |
| 139 | * Insulin secretion_Homo sapiens_hsa04911 | 0.10457400 |

